Prognostic implications of preoperative diagnosis of clinically local and locally advanced prostatic cancer
- Autores: Matveev VB1, Volkova MI1, Mitin AA1, Kalinin SA1, Ermilova VD1, Matveev VB1, Volkova MI1, Mitin AA1, Kalinin SA1, Ermilova VD1
-
Afiliações:
- Edição: Nº 2 (2009)
- Páginas: 37-42
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277357
- ID: 277357
Citar
Texto integral
Resumo
Sobre autores
V Matveev
M Volkova
A Mitin
S Kalinin
V Ermilova
V Matveev
M Volkova
A Mitin
S Kalinin
V Ermilova
Bibliografia
- Van den Ouden D., Schrцder F. H. Management of locally advanced prostate cancer. 1. Staging, natural history, and results of radical surgery. Wld J. Urol. 2000; 18 (3): 194-203.
- Martinez de la Riva S. I., Lцpez-Tomasety J. B., Marrero Dominguez R., Santamaria Blanco P. Perineal radical prostatectomy as monotherapy: ten-year experience. Arch. Esp. Urol. 2004; 57 (4): 397-411.
- Partin A. W., Yoo J., Carter H. B. et al. The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. (Baltimore) 1993; 150 (1): 110-114.
- Dominique S., Ravery V. Preoperative imaging studies: Is there any necessity? EAU Update Ser. 2005; 3 (2): 72-76.
- Oesterling J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol. (Baltimore) 1991; 145 (5): 907-923.
- Stamey T. A., Yang N., Hay A. R. et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 1987; 317 (15): 909-916.
- Levitt J. M., Slawin K. M. Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression. Curr. Urol. Rep. 2007; 8 (4): 269-274.
- Roehrborn C. G., Boyle P., Gould A. L., Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53 (3): 581-589.
- Amiel J., Chevallier D., Peyrottes A. et al. Clinicopathologic and biological correlations (PSA-PAP) in pathology of the prostate. Apropos of 150 cases. J. Urol. (Paris) 1990; 96 (4): 199-201.
- Guimaraes M. S., Quintal M. M., Meirelles L. R. et al. Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy. Int. Braz. J. Urol. 2008; 34 (1): 23-29.
- Chun F. K.-N., Steuber T., Erbesdobler A. et al. Development and internal validation of a nomogramm predicting of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 2006; 49: 820-826.
- Chun F. K.-N., Karakiewicz P. I., Briganti A. et al. Prostate cancer nomograms: An update. Eur. Urol. 2006; 50: 914-916.